Express News | IBio Files Prospectus Relates To Resale From Time To Time Of Up To 10.6M Shares Of Common Stock By Selling Stockholders
Moomoo 24/7Apr 16 16:14 ET
Express News | Ibio Inc -Files Prospectus Relates to Resale From Time to Time of up to 10.6 Mln Shares of Common Stock by Selling Stockholders
Moomoo 24/7Apr 16 16:13 ET
IBio Inc. Raises $15M in Private Placement and Issues Warrants
TipRanksApr 1 16:53 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAvalo Therapeutics (NASDAQ:AVTX) stock rose 289.1% to $18.48 during Friday's pre-market session. The market value of their outstanding shares is at $14.8 million. Xilio Therapeutics (NASDAQ:XLO
BenzingaMar 29 08:06 ET
IBio, Mesoblast, Kodiak Sciences Among Healthcare Movers
Seeking AlphaMar 28 10:01 ET
Trending Stocks Today: Avalo Therapeutics Surges 340% Pre-Market
March 28th - US stocks trending pre-market: Gainers: $Avalo Therapeutics(AVTX.US)$ surges 340% to $20.9 with a turnover of $19.54 million. $Kidpik(PIK.US)$ shoots up 63.91% to $5.36 with a turnover of
moomoo NewsMar 28 07:30 ET
Top Midday Gainers
iBio's (IBIO) shares were up 211% amid heavy trading Wednesday, a day after the company said it signed a securities purchase agreement for a private investment in public equity financing with expected
MT NewswiresMar 27 13:49 ET
SMR, GCTS and GSIW Among Mid-day Movers
Seeking AlphaMar 27 13:22 ET
IBio Climbs After AI-led Drug Discovery Deal
Seeking AlphaMar 27 12:00 ET
IBio Shares Double After Collaboration Agreement With AstralBio
iBio shares doubled after the company entered into a collaboration agreement with AstralBio to discover, engineer and develop novel antibodies to treat obesity and other cardiometabolic conditions.
WSJMar 27 10:08 ET
Micro-Cap Stock IBio Doubles On Wednesday - Here's Why
iBio Inc (NYSE:IBIO) shares are surging after the company entered into a collaboration agreement with AstralBio Inc. on Wednesday to discover, engineer, and develop antibodies to treat obesity and oth
BenzingaMar 27 10:04 ET
IBio, ImmunityBio, Mesoblast Among Healthcare Movers
Seeking AlphaMar 27 10:00 ET
Market-Moving News for March 27th
IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for obesity and cardiometabolic diseases.DRCT: -49% | Direct Digital Holdings s
BenzingaMar 27 08:31 ET
US Futures Trend Higher Wednesday Pre-Bell as Investors Eye Impending Economic, Inflation Data Readings
US stock futures were trending higher in Wednesday's premarket session ahead of a relatively quiet day on the economic calendar as many investors are likely looking ahead to tomorrow's jobless claims
MT NewswiresMar 27 08:16 ET
Trending Stocks Today: IBio Inc Surges 84.34% Pre-Market
March 27th - US stocks trending pre-market: Gainers: $iBio Inc(IBIO.US)$ surges 84.34% to $2.12 with a turnover of $14.96 million. $Trump Media & Technology(DJT.US)$ jumps 13.12% to $65.6 with a turno
moomoo NewsMar 27 07:50 ET
Top Premarket Gainers
MariaDB (MRDB) shares surged 82% in recent Wednesday premarket activity a day after Progress Software (PRGS) said it is looking into a possible offer to acquire MariaDB at $0.60 per share. iBio (IBIO)
MT NewswiresMar 27 07:41 ET
IBio and AstralBio Announce Transformative AI Drug Discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative AI/Machine Learning platform to discover, engineer and develop
GlobeNewswireMar 27 07:00 ET
IBio Announces $15 Million Private Placement
Seeking AlphaMar 27 03:13 ET
Express News | Reported Earlier, IBio Raises $15M In Equity Financing, Shares Set At $2.85 Each
Moomoo 24/7Mar 27 02:28 ET
Press Release: IBio Announces $15.0 Million Private Placement
iBio Announces $15.0 Million Private Placement -- Purchase price of $2.85 represents a premium of 148+% to last close -- BRYAN, Texas and SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NY
Dow JonesMar 26 19:35 ET
No Data
No Data